ArticleAnnals of the rheumatic diseases2022

Behçet's disease risk-variant HLA-B51/ERAP1-Hap10 alters human CD8 T cell immunity.

Ann Cavers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.